Table 1: Impact of emicizumab on common blood tests and haemophilia-specific clotting
assays, including key assays recommended for use in patients receiving emicizumab
emicizumab-table-1
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.